Sudarshan Pharma Industries Limited (SPIL), a company located in Mumbai, was established in 2008. Its primary function is to procure and distribute generic formulations through a contract manufacturing facility. Additionally, the company is involved in the import and export of products and supplies specialty chemicals, Active Pharmaceutical Ingredients (API), and intermediates. To meet the needs and specifications of its clients, SPIL outsources manufacturing facilities from both Indian and foreign suppliers.
The company provides versatile products that can be used across various industries such as paint, food, pharmaceuticals, and adhesives. Additionally, the company is engaged in contract manufacturing services, and supplies pharmaceutical formulations to hospitals, NGOs, government agencies, and healthcare institutes. SPIL offers a range of 50 pharmaceutical formulations in the form of tablets, ointments, capsules, and injectables under their own brand name.
Sudarshan Pharma Industries IPO Details
| IPO Date | Mar 9, 2023 to Mar 14, 2023 |
| Listing Date | Mar 22 2023 |
| Face Value | ₹10 per share |
| Price | ₹71 to ₹73 per share |
| Lot Size | 1600 Shares |
| Issue Size | 6,862,400 shares of ₹10 (aggregating up to ₹50.10 Cr) |
| Fresh Issue | 6,862,400 shares of ₹10 (aggregating up to ₹50.10 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE SME |
| P/E (x) | 21.28 |
| Market Cap (₹ Cr.) | 175.68 |
Sudarshan Pharma Industries IPO Tentative Dates
| Event | Tentative Date |
| Opening Date | Mar 9, 2023 |
| Closing Date | Mar 14, 2023 |
| Basis of Allotment | Mar 17, 2023 |
| Initiation of Refunds | Mar 20, 2023 |
| Credit of Shares to Demat | Mar 21, 2023 |
| Listing Date | Mar 22, 2023 |
Company Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
| 31-Mar-21 | 9,926.02 | 19,372.82 | 267.12 | 2,250.74 | 1,296.05 | 2,977.09 |
| 31-Mar-22 | 13,752.18 | 35,755.89 | 530.37 | 2,977.53 | 2,002.63 | 3,059.24 |
| 30-Sep-22 | 16,402.22 | 19,589.87 | 360.70 | 5,108.79 | 3,996.89 | 4,940.50 |
| Amount in ₹ Lakhs |
Objects of the Issue
The Company intends to utilize the Net Fresh Issue Proceeds for the following Objects:
- Working Capital Requirements
- General Corporate Purposes.
udarshan Pharma Industries IPO Prospectus
Company Contact Information
Sudarshan Pharma Industries Ltd
301,3rd Floor, Aura Biplex,
Above Kalyan Jewellers S. V. Road, Borivali (West)
Mumbai – 400092
Phone: 022- 42221111
Email: compliance@sudarshanpharma.com
Website: http://www.sudarshanpharma.com/
Sudarshan Pharma Industries IPO Registrar
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: einward.ris@kfintech.com
Website: https://karisma.kfintech.com/
Sudarshan Pharma Industries IPO Lead Manager(s)
- Gretex Corporate Services Pvt Ltd (Past IPO Performance)
, a company located in Mumbai, was established in 2008. Its primary function is to procure){kind=link}